openPR Logo
Press release

What's driving the Global Drug Delivery Systems Market trends? Key Players are World Health Organization, Diabetes UK, PhRMA, International Diabetes Federation

06-28-2019 02:12 PM CET | Health & Medicine

Press release from: marketstudyreport

/ PR Agency: marketstudyreport
Global Drug Delivery Systems Market

Global Drug Delivery Systems Market

Market Study Report LLC: The Report entitled 2018-2027 Global Drug Delivery Systems Market Report explores the essential factors of the Drug Delivery Systems Market considering such as industry situations, market demands, market players adopted business strategies and their growth scenario. The Global Drug Delivery Systems Market has been separated by this report based on the key players profiles, Type, Application and Regions.

Global drug delivery systems market, based on the route of administration was segmented into oral, transmucosal, injectable, topical, implantable, and ocular. Oral drug delivery system segment led the market for drug delivery systems market in 2018, owing to its ease of administration and increasing demand by the patient population for various therapeutic areas. Based on the distribution channels, the drug delivery systems market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies held the major share owing to the availability of larger range of medications required for the treatment of patient population for various medical conditions. On the basis of application, the market is segmented into hospital & clinics, home care settings, and others. The hospitals and clinics segment held the major share in 2018. This is primarily attributed to the significant number of patient visits to hospitals and the requirement of large volumes of drugs and their respective delivery devices to fulfil to the demand of the large patient population.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/2095764?utm_source=openpr.com-Mahadev

The traditional drug delivery techniques, like intramuscular, intravenous, oral and rectal drug administration are not suitable to certain patient populations. The non-invasive methods of drug delivery reduces dosing frequency and simplifies dosing schedules. Moreover, non-invasive drug delivery system can significantly reduce the cost of clinical use because of self-administration of the drugs by the patients. The manufacturing cost may also be less for non-invasive dosage forms as compared to injections in many cases. For instance, inhaled insulin appears to be a non-invasive, well-tolerated and liked modality of treatment of diabetes. In 2014, MannKind Corporation developed Afrezza (insulin human) inhalation powder which was approved by FDA. Thus, due to advantages offered by non-invasive drug delivery devices the drug delivery market is expected to witness growth during the forecast period.

The global drug delivery systems market is expected to reach US$ 2,302.2 Bn in 2027 from US$ 1,243.1 Bn in 2018. The market is estimated to grow with a CAGR of 7.2% from 2019-2027.

The market is driven by the factors such as, rising incidence of chronic diseases, growing demand for non-invasive drug delivery devices, increasing R&D expenditures in and pharmaceutical and medical device companies. However, the factors restraining the market growth are high cost involved in development of drug delivery devices and product recalls.

With the improvements in medical devices and certain transdermal delivery technologies, the non-invasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. The Non-Invasive Drug Delivery Systems encompasses the broad field of non-invasive drug delivery systems which includes drug delivery via topical, transdermal-active (device- aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, as well as delivery via alveolar membrane from inhaled medication. Patient compliance has been found to be much higher when administrated by non-invasive routes due to decreased pain involved in drug delivery and therefore these techniques are considered to be a preferred mode of drug delivery.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/2095764?utm_source=openpr.com-Mahadev

Some of the major primary and secondary sources included in the report for the drug delivery systems market are World Health Organization, International Society for Aerosols in Medicine (ISAM), National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes UK, Pharmaceutical Research and Manufacturers of America (PhRMA), Inhalation Drug Delivery Association (IDDA), American Lung Association, Centers for Disease Control and Prevention, Chinese Diabetes Society, International Diabetes Federation and others.

Table of content:

Chapter 1. Introduction
Chapter 2. Global Drug Delivery Systems Market - Key Takeaways
Chapter 3. Research Methodology
Chapter 4. Global Drug Delivery Systems- Market Landscape
Chapter 5. Drug Delivery Systems Market - Key Market Dyanamics
Chapter 6. Drug Delivery Systems Market - Global Analysis
Chapter 7. Drug Delivery Systems Market - Global Regulatory Scenario
Chapter 8. Drug Delivery Systems Market Analysis And Forecasts To 2027 - Route Of Administration
Chapter 9. Global Drug Delivery Systems Market Analysis- By Distribution Channel
Chapter 10. Global Drug Delivery Systems Market Analysis- By Application

More Details on this Report At: https://www.marketstudyreport.com/reports/drug-delivery-systems-market-to-2027-global-analysis?utm_source=openpr.com-Mahadev

Related Report:

Global (United States, European Union and China) Needle-Free Drug Delivery Systems Market Research Report 2019-2025
This report studies the global market size of Needle-Free Drug Delivery Systems, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Needle-Free Drug Delivery Systems production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
Read More: https://www.marketstudyreport.com/reports/global-united-states-european-union-and-china-needle-free-drug-delivery-systems-market-research-report-2019-2025

Unit Dose Drug Delivery Systems Market Insights 2019, Global and Chinese Analysis and Forecast to 2024

Unit Dose Drug Delivery Systems Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Unit Dose Drug Delivery Systems industry with a focus on the Chinese market. The report provides key statistics on the market status of the Unit Dose Drug Delivery Systems manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Unit Dose Drug Delivery Systems market covering all important parameters.
Read More: https://www.marketstudyreport.com/reports/unit-dose-drug-delivery-systems-market-insights-2019-global-and-chinese-analysis-and-forecast-to-2024

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Global Drug Delivery Systems Market trends? Key Players are World Health Organization, Diabetes UK, PhRMA, International Diabetes Federation here

News-ID: 1791457 • Views:

More Releases from marketstudyreport

At 6.1% CAGR, High Voltage Circuit Breaker (33KV-765KV) Market Size is Expected to Exhibit USD 6178.6 Mn by 2028 | GE Grid Solutions, ABB Ltd, Hitachi, Siemens AG, Mitsubishi Electric Corporation & More
At 6.1% CAGR, High Voltage Circuit Breaker (33KV-765KV) Market Size is Expected …
Global High Voltage Circuit Breaker Market Report by Market Study report scrutinizes the overall market synopsis globally, their restraining factors, drivers, major challenges, opportunities, latest trends to stabilize the global High Voltage Circuit Breaker (33KV-765KV) market situation, future developmental plans, and values pertaining to various marketing states. This global High Voltage Circuit Breaker (33KV-765KV) market report also enables users to make a decision and considering the overall market feasibility. It
Global Diabetes Dietary Supplements Market size to witness 4.2% CAGR through 2028 | Nestlé Health Science, Lysulin Inc., Hexagon Nutrition Pvt. Ltd., Dr. Reddy's Laboratories Ltd., Danone S.A., Caelus Health
Global Diabetes Dietary Supplements Market size to witness 4.2% CAGR through 202 …
Market Study Report presents latest report on, global diabetes dietary supplements market is predicted to grow at a CAGR of about 4.2% over the forecast period.The increasing prevalence of diabetes, the soaring geriatric population, and surging awareness about supplements are some of the chief factors driving the growth of global diabetes dietary supplements market. The competitive landscape of global diabetes dietary supplements industry is defined by companies such as Nutricia, Nature's
Automotive Steel Market size is projected to reach USD 193230.61 million by 2028| ArcelorMittal, Baowu, POSCO, ThyssenKrupp, Nippon Steel, HYUNDAI
Automotive Steel Market size is projected to reach USD 193230.61 million by 2028 …
Global Automotive Steel Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. Global Automotive Steel Market Size was estimated at USD 134610 million in 2021 and is projected to reach USD 193230.61 million by 2028, exhibiting a CAGR of 5.21%
Data Center Construction Market size projected to reach USD 54902.09 million by 2028 | Whiting-Turner Contracting, Turner Construction, Holder Construction, DPR Construction
Data Center Construction Market size projected to reach USD 54902.09 million by …
Global Data Center Construction Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. Global Data Center Construction Market Size was estimated at USD 26780 million in 2021 and is projected to reach USD 54902.09 million by 2028, exhibiting a CAGR

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug